These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 7577996)
21. Phospholipid regulates the activation of factor X by tissue factor/factor VIIa (TF/VIIa) via substrate and product interactions. Hathcock JJ; Rusinova E; Gentry RD; Andree H; Nemerson Y Biochemistry; 2005 Jun; 44(22):8187-97. PubMed ID: 15924438 [TBL] [Abstract][Full Text] [Related]
22. Lipid specificity of the membrane binding domain of coagulation factor X. Muller MP; Wang Y; Morrissey JH; Tajkhorshid E J Thromb Haemost; 2017 Oct; 15(10):2005-2016. PubMed ID: 28782177 [TBL] [Abstract][Full Text] [Related]
23. Selection and characterization of a new class of peptide exosite inhibitors of coagulation factor VIIa. Dennis MS; Roberge M; Quan C; Lazarus RA Biochemistry; 2001 Aug; 40(32):9513-21. PubMed ID: 11583150 [TBL] [Abstract][Full Text] [Related]
24. Interaction of activated factor VII and active site-inhibited activated factor VII with tissue factor. Sørensen BB; Rao LV Blood Coagul Fibrinolysis; 1998 Mar; 9 Suppl 1():S67-71. PubMed ID: 9819031 [TBL] [Abstract][Full Text] [Related]
25. Phosphatidylserine and Phosphatidylethanolamine Bind to Protein Z Cooperatively and with Equal Affinity. Sengupta T; Manoj N PLoS One; 2016; 11(9):e0161896. PubMed ID: 27584039 [TBL] [Abstract][Full Text] [Related]
26. Molecular determinants involved in differential behaviour between soluble tissue factor and full-length tissue factor towards factor VIIa. Prasad R; Sen P Phys Chem Chem Phys; 2017 Aug; 19(33):22230-22242. PubMed ID: 28799584 [TBL] [Abstract][Full Text] [Related]
27. Factor VIIa/tissue factor generates a form of factor V with unchanged specific activity, resistance to activation by thrombin, and increased sensitivity to activated protein C. Safa O; Morrissey JH; Esmon CT; Esmon NL Biochemistry; 1999 Feb; 38(6):1829-37. PubMed ID: 10026263 [TBL] [Abstract][Full Text] [Related]
28. The effects of shear rate on the enzymatic activity of the tissue factor-factor VIIa complex. Gemmell CH; Nemerson Y; Turitto V Microvasc Res; 1990 Nov; 40(3):327-40. PubMed ID: 2084499 [TBL] [Abstract][Full Text] [Related]
29. The effect of membrane composition on the hemostatic balance. Smirnov MD; Ford DA; Esmon CT; Esmon NL Biochemistry; 1999 Mar; 38(12):3591-8. PubMed ID: 10090745 [TBL] [Abstract][Full Text] [Related]
30. The tissue factor/factor VIIa/factor Xa complex: a model built by docking and site-directed mutagenesis. Norledge BV; Petrovan RJ; Ruf W; Olson AJ Proteins; 2003 Nov; 53(3):640-8. PubMed ID: 14579355 [TBL] [Abstract][Full Text] [Related]
31. Cholesterol affects divalent cation-induced fusion and isothermal phase transitions of phospholipid membranes. Shavnin SA; Pedroso de Lima MC; Fedor J; Wood P; Bentz J; Düzgüneş N Biochim Biophys Acta; 1988 Dec; 946(2):405-16. PubMed ID: 3207754 [TBL] [Abstract][Full Text] [Related]
32. Incorporation of danyslated phospholipids and dehydroergosterol into membranes using a phospholipid exchange protein. Muczynski KA; Stahl WL Biochemistry; 1983 Dec; 22(25):6037-48. PubMed ID: 6318806 [TBL] [Abstract][Full Text] [Related]
33. The action of high-dose factor VIIa (FVIIa) in a cell-based model of hemostasis. Hoffman M; Monroe DM Dis Mon; 2003 Jan; 49(1):14-21. PubMed ID: 12525825 [TBL] [Abstract][Full Text] [Related]
34. The Role of Putative Phosphatidylserine-Interactive Residues of Tissue Factor on Its Coagulant Activity at the Cell Surface. Ansari SA; Pendurthi UR; Sen P; Rao LV PLoS One; 2016; 11(6):e0158377. PubMed ID: 27348126 [TBL] [Abstract][Full Text] [Related]
35. Structural modulation of factor VIIa by full-length tissue factor (TF Prasad R; Sen P J Biomol Struct Dyn; 2018 Feb; 36(3):621-633. PubMed ID: 28150568 [TBL] [Abstract][Full Text] [Related]
36. Tissue factor- and factor X-dependent activation of protease-activated receptor 2 by factor VIIa. Camerer E; Huang W; Coughlin SR Proc Natl Acad Sci U S A; 2000 May; 97(10):5255-60. PubMed ID: 10805786 [TBL] [Abstract][Full Text] [Related]
37. Strength of Ca(2+) binding to retinal lipid membranes: consequences for lipid organization. Huster D; Arnold K; Gawrisch K Biophys J; 2000 Jun; 78(6):3011-8. PubMed ID: 10827979 [TBL] [Abstract][Full Text] [Related]
38. Importance of phosphatidylethanolamine for association of protein kinase C and other cytoplasmic proteins with membranes. Bazzi MD; Youakim MA; Nelsestuen GL Biochemistry; 1992 Feb; 31(4):1125-34. PubMed ID: 1734960 [TBL] [Abstract][Full Text] [Related]
39. Molecular and cell biology of phosphatidylserine and phosphatidylethanolamine metabolism. Vance JE Prog Nucleic Acid Res Mol Biol; 2003; 75():69-111. PubMed ID: 14604010 [TBL] [Abstract][Full Text] [Related]
40. Substitution of aspartic acid for methionine-306 in factor VIIa abolishes the allosteric linkage between the active site and the binding interface with tissue factor. Persson E; Nielsen LS; Olsen OH Biochemistry; 2001 Mar; 40(11):3251-6. PubMed ID: 11258943 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]